Draeger, BD, Edwards, Philips, Cardinal Health, Medline, and Nova Biomedical issued major recalls in October 2026 after ...
Edwards Lifesciences raised its 2026 guidance for the third time this year, citing strong TAVR growth, new clinical data, and ...
Siemens Healthineers is rebranding as "Healthineers" after its 2027 split from Siemens, while spinning off diagnostics as ...
The softer sales, along with reimbursement pressure in wound care, caused the London-based company to miss Wall Street ...
Cochlear completes pivotal trial enrollment for its fully implantable hearing device. CTO shares insights on design, safety, ...
Guardant Health's Shield blood test wins the 2026 Prix Galien USA Award for Best Medical Technology, recognizing its impact ...
Boston Scientific's SIMPLAAFY data show aspirin alone or reduced-dose anticoagulation matches DAPT after Watchman Flx Pro ...
Few medtech firms use FDA's PCCP pathway because most lack the MLOps infrastructure needed to safely iterate AI models ...
Boston Scientific cuts Q4 guidance as cyberattack fallout and EP and Watchman market pressures weigh on growth heading into ...
Explore questions and considerations that come into play when moving an additive application from design freeze toward ...
Stryker lowered its 2026 sales and EPS guidance after a Q3 miss, citing slowing joint replacement demand and ...
New data from Edwards Lifesciences' PROGRESS Trial is poised to change how clinicians approach moderate aortic stenosis. Presented as a late-breaking trial at Transcatheter Cardiovascular Therapeutics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results